AB

Aditya Brahmashekhar Dixit

Active Director Director DIN 02756625
DIN 02756625 First appointment Nov 2009 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Aditya Brahmashekhar Dixit

Data last updated:

Aditya Brahmashekhar Dixit is a Director at Atre Medical Products Limited (since 2009). The company operates in Healthcare.

DIN 02756625
Primary Designation Director
Industry Healthcare
First Appointment 30 Nov 2009
Oldest Company Age 31 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atre Medical Products Limited U33110MH1995PLC092633
Director30 Nov 20091995Active

Board colleagues of Aditya Brahmashekhar Dixit

Directorship timeline

Open interactive timeline →
Atre Medical Products Limited
Premium access

Shareholding and investment profile for Aditya Brahmashekhar Dixit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aditya Brahmashekhar Dixit

Aditya Brahmashekhar Dixit currently holds 1 directorship: Atre Medical Products Limited (Director, since 30 Nov 2009).

Aditya Brahmashekhar Dixit was first appointed on 30 Nov 2009 as Director at Atre Medical Products Limited.

The current boards of Aditya Brahmashekhar Dixit's companies include Balramesh Lahanu Pawar (Atre Medical Products Limited), Madhav Babanrao Dhiwar (Atre Medical Products Limited), Vivek Atmaram Atre (Atre Medical Products Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available